Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 674

1.

Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats.

Araujo PX, Costa TJ, Echem C, Aparecida de Oliveira M, Santos-Eichler RA, Colli LG, Jiménez-Altayó F, Vila E, Akamine EH, Dantas AP, Ceravolo GS, de Carvalho MHC.

J Pharmacol Exp Ther. 2017 Jul;362(1):98-107. doi: 10.1124/jpet.117.240465. Epub 2017 May 22.

2.
3.

Serum vitamin D and sex hormones levels in men and women: The Multi-Ethnic Study of Atherosclerosis (MESA).

Zhao D, Ouyang P, de Boer IH, Lutsey PL, Farag YM, Guallar E, Siscovick DS, Post WS, Kalyani RR, Billups KL, Michos ED.

Maturitas. 2017 Feb;96:95-102. doi: 10.1016/j.maturitas.2016.11.017. Epub 2016 Nov 29.

PMID:
28041602
4.

[Coronary disease in women: The role of sexual hormones].

Vautrin E, Marlière S, Bouvaist H, Guerbaai R, Barone-Rochette G.

Ann Cardiol Angeiol (Paris). 2016 Dec;65(6):404-410. doi: 10.1016/j.ancard.2016.10.007. Epub 2016 Nov 1. Review. French.

PMID:
27814783
5.

Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.

Myasoedova VA, Kirichenko TV, Melnichenko AA, Orekhova VA, Ravani A, Poggio P, Sobenin IA, Bobryshev YV, Orekhov AN.

Int J Mol Sci. 2016 Aug 11;17(8). pii: E1318. doi: 10.3390/ijms17081318.

6.

Estrogens and Coronary Artery Disease: New Clinical Perspectives.

Meyer MR, Barton M.

Adv Pharmacol. 2016;77:307-60. doi: 10.1016/bs.apha.2016.05.003. Epub 2016 Jun 29.

PMID:
27451102
7.

Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.

Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ.

Neurology. 2016 Aug 16;87(7):699-708. doi: 10.1212/WNL.0000000000002980. Epub 2016 Jul 15.

PMID:
27421538
8.

Hormonalna terapia zastępcza a choroby układu sercowo-naczyniowego.

Lesiak M, Mariola RL, Podkowa N.

Ginekol Pol. 2016;87(1):59-64. doi: 10.17772/gp/61022.

9.

Sex hormone therapy and progression of cardiovascular disease in menopausal women.

Alhurani RE, Chahal CA, Ahmed AT, Mohamed EA, Miller VM.

Clin Sci (Lond). 2016 Jul 1;130(13):1065-74. doi: 10.1042/CS20160042. Review.

10.

Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women.

da Silva LH, Panazzolo DG, Marques MF, Souza MG, Paredes BD, Nogueira Neto JF, Leão LM, Morandi V, Bouskela E, Kraemer-Aguiar LG.

Climacteric. 2016 Aug;19(4):337-43. doi: 10.1080/13697137.2016.1180676. Epub 2016 May 12.

PMID:
27170466
11.

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP; ELITE Research Group.

N Engl J Med. 2016 Mar 31;374(13):1221-31. doi: 10.1056/NEJMoa1505241.

12.

Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.

Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RD.

Neurobiol Aging. 2016 Apr;40:155-63. doi: 10.1016/j.neurobiolaging.2016.01.011. Epub 2016 Jan 29.

13.

Association of adipokines and estradiol with bone and carotid calcifications in postmenopausal women.

Värri M, Niskanen L, Tuomainen T, Honkanen R, Kröger H, Tuppurainen MT.

Climacteric. 2016 Apr;19(2):204-11. doi: 10.3109/13697137.2016.1139563. Epub 2016 Feb 5.

PMID:
26849745
14.

Discriminating Between the Roles of Androgens and Estrogens in Cardiovascular Disease.

Manolakou P, Katsiki E, Angelopoulou R, Lavranos G.

Coll Antropol. 2015 Jun;39(2):457-60.

PMID:
26753466
15.

Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis.

Williams MS, Cushman M, Ouyang P, Heckbert SR, Kalyani RR, Vaidya D.

J Womens Health (Larchmt). 2016 Feb;25(2):166-72. doi: 10.1089/jwh.2015.5465. Epub 2015 Dec 24.

16.

Synergistic Effect of a Physiological Ratio of Estradiol and Testosterone in the Treatment of Early-stage Atherosclerosis.

Dai W, Ming W, Li Y, Zheng HY, Wei CD, Rui Z, Yan C.

Arch Med Res. 2015 Nov;46(8):619-29. doi: 10.1016/j.arcmed.2015.11.003. Epub 2015 Nov 26.

PMID:
26633088
17.

Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women.

Sobenin IA, Myasoedova VA, Orekhov AN.

Curr Pharm Des. 2016;22(2):152-63. Review.

PMID:
26561070
18.

Oxidative damage and the pathogenesis of menopause related disturbances and diseases.

Cervellati C, Bergamini CM.

Clin Chem Lab Med. 2016 May;54(5):739-53. doi: 10.1515/cclm-2015-0807. Review.

19.

Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.

Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black DM, Naftolin F, Harman SM, de Andrade M.

Physiol Genomics. 2016 Jan;48(1):33-41. doi: 10.1152/physiolgenomics.00029.2015. Epub 2015 Oct 27.

20.

G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.

Meyer MR, Fredette NC, Barton M, Prossnitz ER.

J Endocrinol. 2015 Oct;227(1):61-9. doi: 10.1530/JOE-15-0257. Epub 2015 Aug 24.

Supplemental Content

Loading ...
Support Center